The post Back-to-school recommendations / eye floaters / colorectal cancer screening guidelines appeared first on Mayo Clinic News Network.
]]>
Whether in person, online or a hybrid model of education, families and school districts are planning for how to safely teach students during the COVID-19 pandemic. No matter which plan is chosen by communities, this school year will be challenging. On Mayo Clinic Q&A radio, Dr. Nipunie Rajapakse, a pediatric infectious disease specialist at Mayo Clinic, discusses how students, teachers and staff can use public health measures already in place to minimize the risk of exposure to the virus and reduce community spread of COVID-19. Also on the podcast, Dr. Amir Khan, a Mayo Clinic ophthalmologist, explains what causes eye floaters. And Dr. Pashtoon Kasi, a Mayo Clinic medical oncologist, explains changes in colorectal cancer screening guidelines to prevent the disease in younger adults.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding along with guidelines and recommendations may have changed since the original publication date.
Check the Centers for Disease Control and Prevention website for additional updates on COVID-19. For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
The post Back-to-school recommendations / eye floaters / colorectal cancer screening guidelines appeared first on Mayo Clinic News Network.
]]>The post Mayo Clinic Radio: Paired kidney donation appeared first on Mayo Clinic News Network.
]]>
A living donor kidney transplant usually involves a donated kidney from someone you know, such as a family member, friend or co-worker. Genetically related family members are most likely to be compatible living kidney donors. You and your living kidney donor are evaluated to determine if the donor's organ is a good match. If not, there is another option available: paired kidney donation.
Paired donation, also known as "paired exchange," may be an option when a donor and intended recipient have incompatible blood types, or when the recipient has unacceptable antibodies against the donor's tissue antigens. In paired donation, two or more organ recipient pairs trade donors, so that the recipients get organs that are compatible with their blood type. A nondirected living donor also can participate in paired donation to match incompatible pairs.
On the next Mayo Clinic Radio program, Dr. Carrie Schinstock, a Mayo Clinic nephrologist, and Kay Kosberg, a Mayo Clinic nurse who coordinates the paired kidney donation program across Mayo Clinic's Arizona, Florida and Rochester campuses, will discuss the paired kidney donation program at Mayo Clinic. Also on the program, Dr. Amir Khan, a Mayo Clinic ophthalmologist, will explain what causes eye floaters. And Dr. Pashtoon Kasi, a Mayo Clinic medical oncologist, will explain changes in colorectal cancer screening guidelines to prevent the disease in younger adults.
To hear the program, find an affiliate in your area.
Miss the show? Here's your Mayo Clinic Radio podcast.
Use the hashtag #MayoClinicRadio, and tweet your questions.
Mayo Clinic Radio is on iHeartRadio.
Access archived shows or subscribe to the podcast.
Mayo Clinic Radio produces a weekly one-hour radio program highlighting health and medical information from Mayo Clinic.
The post Mayo Clinic Radio: Paired kidney donation appeared first on Mayo Clinic News Network.
]]>The post Mayo Clinic Radio: Paired kidney donation / eye floaters / colorectal cancer in younger adults appeared first on Mayo Clinic News Network.
]]>Paired donation, also known as "paired exchange," may be an option when a donor and intended recipient have incompatible blood types, or when the recipient has unacceptable antibodies against the donor's tissue antigens. In paired donation, two or more organ recipient pairs trade donors, so that the recipients get organs that are compatible with their blood type. A nondirected living donor also can participate in paired donation to match incompatible pairs.
On the next Mayo Clinic Radio program, Dr. Carrie Schinstock, a Mayo Clinic nephrologist, and Kay Kosberg, a Mayo Clinic nurse who coordinates the paired kidney donation program across Mayo Clinic's Arizona, Florida and Rochester campuses, will discuss the paired kidney donation program at Mayo Clinic. Also on the program, Dr. Amir Khan, a Mayo Clinic ophthalmologist, will explain what causes eye floaters. And Dr. Pashtoon Kasi, a Mayo Clinic medical oncologist, will explain changes in colorectal cancer screening guidelines to prevent the disease in younger adults.
To hear the program, find an affiliate in your area.
Miss the show? Here's your Mayo Clinic Radio podcast.
Use the hashtag #MayoClinicRadio, and tweet your questions.
Mayo Clinic Radio is on iHeartRadio.
Access archived shows or subscribe to the podcast.
Mayo Clinic Radio produces a weekly one-hour radio program highlighting health and medical information from Mayo Clinic.
The post Mayo Clinic Radio: Paired kidney donation / eye floaters / colorectal cancer in younger adults appeared first on Mayo Clinic News Network.
]]>The post Updated guidelines for colorectal cancer screening appeared first on Mayo Clinic News Network.
]]>
The American Cancer Society has announced updated guidelines as to when most folks should begin being screened for colon and rectal cancer. Colon and rectal cancer kills thousands of people every year. In fact, it's the third leading cause of cancer-related deaths in the U.S. The updated recommendations are that adults at average risk should start regular screening at age 45, five years earlier than the former recommendations.
Dr. Jonathan Leighton, a Mayo Clinic gastroenterologist, points to one big reason behind the change: "There has been a recent increase in the development of colorectal cancers in younger individuals, under the age of 50. And, so, for that reason ─ because of this alarming increase in this population ─ the American Cancer Society decided to lower the age of screening to 45." Dr. Leighton says it is the hope that lowering the screening age to detect polyps and colorectal cancer at an earlier stage will save lives and improve overall outcomes. Other societies have not yet changed the age of screening, so, "in the meantime, I think patients need to discuss this with their physicians, and through shared decision-making, decide what's the best age for them."
Watch: Dr. Leighton discusses the updated colorectal cancer screening guidelines.
Journalists: Broadcast-quality sound bites with Dr. Leighton are in the downloads.
The post Updated guidelines for colorectal cancer screening appeared first on Mayo Clinic News Network.
]]>The post Task Force Cancer Screening Recommendations Now Include Stool DNA Test appeared first on Mayo Clinic News Network.
]]>
ROCHESTER, Minn. -- The United States Preventive Services Task Force has issued its final colorectal cancer screening recommendations for 2016. The Task Force assigns an overall “A” grade to colorectal cancer (CRC) screening in people ages 50-75, and fully recommends several screening exams that now includes Cologuard, the stool DNA test codeveloped by Mayo Clinic and Exact Sciences.
“The task force decision to include Cologuard will make this accurate and noninvasive new colorectal cancer screening option available to millions of people who may be unable or unwilling to undergo colonoscopy,” says David Ahlquist, M.D., a gastroenterologist at Mayo Clinic and co-inventor of the test. “This decision will help save lives.”
The task force recommendations also recognize the use of Cologuard every three years, in keeping with the recommendation of the American Cancer Society and the coverage interval established by the Centers for Medicare and Medicaid Services.
MEDIA CONTACT: Joe Dangor, Mayo Clinic Public Affairs, 507-284 5005, newsbureau@mayo.edu
Colorectal cancer is the second leading cause of cancer death among men and women. According to the American Cancer Society, more than 134,000 people will develop colorectal cancer in 2016, and more than 49,000 will die of the disease.
In August 2014, Mayo Clinic became the first health care organization to offer Cologuard. The Cologuard technology platform was codeveloped by Exact Sciences Corp. and Mayo Clinic as part of a broad, exclusive collaboration.
Dr. Ahlquist and Mayo Clinic have a financial interest in Cologuard. Neither Mayo Clinic nor Dr. Ahlquist receives royalties for Cologuard tests ordered for Mayo Clinic patients by Mayo Clinic physicians.
About Exact Sciences
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. For more information, follow Exact Sciences on Twitter @ExactSciences, or on Facebook.
About Cologuard
Cologuard was approved by the U.S. Food and Drug Administration in August 2014, and results from Exact Sciences' prospective 90-site, point-in-time, 10,000-patient pivotal trial were published in the New England Journal of Medicine in March 2014. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society, and stool-DNA is listed in the screening guidelines of the U.S. Multi-Society Task Force on Colorectal Cancer. Cologuard is indicated to screen adults of either sex, 50 years or older, who are at average risk for colorectal cancer. Cologuard is not for everyone and is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high-risk individuals. Falsepositives and false negatives do occur. Any positive test result should be followed by a diagnostic colonoscopy. Following a negative result, patients should continue participating in a screening program at an interval and with a method appropriate for the individual patient. Cologuard performance when used for repeat testing has not been evaluated or established. For more information about Cologuard,visit http://www.CologuardTest.com. Rx Only.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or https://newsnetwork.mayoclinic.org/.
The post Task Force Cancer Screening Recommendations Now Include Stool DNA Test appeared first on Mayo Clinic News Network.
]]>